KRChoksey has recommended an "ACCUMULATE" rating for Cipla Ltd. with a target price of Rs 1,680, indicating a potential upside of 6.0% from the current market price of Rs 1,585.

KRChoksey has reaffirmed a ‘Buy’ recommendation for Supriya Lifescience Ltd.

Prabhudas Lilladher has issued an “Accumulate” rating on Cipla’s stock, suggesting a target price (TP) of Rs1,615 per share, with the current market price (CMP) standing at Rs1,478.

Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.

Prabhudas Lilladher has issued a BUY recommendation for Eris Lifesciences, setting a target price of Rs 1,420.

Morningstar has issued a HOLD recommendation on Merck & Co. Inc., maintaining a fair value estimate of $120, with the stock currently trading at $105.88.